Pharma Supply Chain & Security World 2024 | Corvus Global Events | 12 March 2024 | Holiday Inn London - Kensington, Wrights Lane, Kensington, London W8 5SP, USA

The summit is back in London for the 6th time, and this time with more focus on optimizing your supply chain challenges to ensure an agile, responsive, streamlined and secured supply chain. The pharmaceutical supply chains are facing a significant challenge in the form of counterfeit drugs that are entering the supply chain from various points at different levels. Pharmaceutical companies that adopt an effective serialisation program have end-to-end visibility and traceability for all of their packaging, labelling, and distribution. This enables them to rapidly identify and quarantine counterfeit products. This helps to protect patients, consumers worldwide, brand equity, reputations and the company's revenue stream by ensuring compliance with regulatory requirements for serialisation of medicines in emerging markets. The rise of the digital supply chain has been accompanied by an ever-increasing number of regulations that have accelerated its development and adoption. Years ago, the pharmaceutical supply chain regulated only manufacturing and distribution. However, with a rise in economic impact of counterfeit drugs on society, there have been attempts to improve serialisation processes even further.

In spite of past obstacles, innovations like IoT, AI and ML (and Blockchain) have led us into an exciting era of digitization within our industry. Data-driven algorithms and analytics will transform the pharmaceutical supply chain, helping it become more intuitive. With AI's predictive power combined with ML capabilities to analyse data in a speedy fashion, pharma companies can use this information towards making smarter decisions that lead to greater success throughout all stages of their operations. Combining AI with other advanced technologies, such as blockchain, can create a system that is immutable and transparent. This will also allow for the security of products to be improved in the long run by shielding from counterfeit drugs or substandard medicines.

KEY HIGHLIGHTS - CREATING VALUE ACROSS THE SUPPLY CHAIN
• Streamlining your supply chain
• End to End supply chain visibility
• Designing an optimal supply chain network
• Strategies for drug anti-counterfeiting in global supply chain and improving security through an interlinked supply chain strategy
• Developing a sustainable Serialization strategy
• Integration of track & trace solutions in production and supply chain
• Smart Packaging, Labelling and Artwork
• Warehouse & Logistics
• Serialization Data and Analytics driven approach to increase supply chain agility
• Adoption of Blockchain in pharma supply chain
• Intelligent Automation enabling Industry 4.0
• The need to understand and adopt new technologies like IoT, Analytics, Machine Learning and Artificial Intelligence
• Effective Authentication Technologies
• Best selection of tamper-evident features
• Brand Protection & Securing supply chain integrity
• Global enterprise level solutions for anti-counterfeiting
• Tackling pharmaceutical crime - initiatives at multinational, EU and national level
• IP and regulatory enforcement
• Synchrony of the Pharma Industry and professional bodies against counterfeiting
• Understanding and meeting the needs of DSCSA, EU FMD and other global regulations
• Strategies for public awareness and patient protection
• Best practices to protect your brand
• The role of the Internet in aiding the counterfeiters – How to overcome the situation?
• How Pharma Industry and professional bodies are fighting against counterfeiting
• Developing a RMP for your supply chain to protect your Brand, Product and Patient Safety
• Case study: How companies are structuring their counterfeiting efforts and departments?

2024 Speakers

Alexandru Popa
Associate Director and Blockchain for Pharma Supply Chain, MSD

Harry Hughes
Managing Director, FET Logistics Ltd

Dominik G. Rabus
Head of NIRONE Product Conformity Solutions, Spectral Engines GmbH

Phil Blunden
Defence Assurance & Information Security, UK Ministry of Defence

Dan Manolescu
Director, Global Privacy Legal Counsel, AstraZeneca (RDU)

Stephen Wilkins
CEO, Davies Development and Testing

Radovan Simic
Product Flow & Sustainability Lead, Bayer

Gianpiero Lorusso
Former Director, Head of Upstream Logistics (Global), Healthcare Business of Merck

Heiko Trefzger
Product Manager Data & Insights, Roche

Duccio Lombardi
Serialization Manager - Corporate Global Quality Management, Menarini

David Fairnie
Principal Consultant - Supply Chain Risk Management and Resilience - EMEA, BSI

Himanshu Agrawal
Director - Global Process Owner & Digital Innovation Lead, Supply Chain Logistics, GSK, Pharmaledger

Henry Moran
Director, ASC Associates Ltd

Florian Meichelbock
E2E Senior Supply Network Manager, Bayer Consumer Health

Delphine Marchal
Associate Vice President, Assistant General Counsel, Regulatory Legal Team, Eli Lilly

Jaya Mishra
Associate Director Strategy, Strategic Transformation Unit | Global Healthcare Operations, Merck Healthcare

Andrew Smith
Former Technical Packaging Director, GSK

Faris Hattar
Associate Director of Supply Chain, Hikma Pharmaceuticals

Leonid Sharanov
Former Serialization and Traceability SME | Track & Trace Lead, Johnson & Johnson

Meta He
Sales & Marketing, Beijing Acctrue Technology

Claire Crabtree
Senior Supplier Risk Manager, Roche

Syed Saqib Naqvi
Supply Chain Digital Lead, Amicus Therapeutics

Grant Courtney
Principal Consultant, Smarter and Safer Products (on behalf of UNICEF)

Max Kabalisa
Manager, Digitalisation and Traceability, UNICEF Supply Division

Neil Piper
Senior Manager AIDC - Healthcare, GS1

Ronan Kenupp
RSV Global Supply Launch Lead - Senior Manager, GSK

Camille Diss
CPO, business & Marketing Manager, EDGYN

Mike Isles
Executive Director, Alliance for Safe Online Pharmacy in the EU European Alliance for Access to Safe Medicines

Stefan Artlich
Director and Global Process Owner 'Track & Trace', Bayer

Melanie Hansen
Supply Chain Manager, AJ vaccines

Maryam A. Babba
Multistakeholder Manager/ Program Lead in PPP (Sustainable Development Consultant-Health), TDi Sustainability

Demet Tazegul
Supply Chain Manager, Sanovel Pharmaceuticals

2024 Sponsors

PLATINUM SPONSOR:
• LSPedia

SILVER SPONSORS:
• Spectral Engines
• BSI
• Edgyn

ASSOCIATE SPONSORS:
• Pharmaledger Association
• Gavion Technologies

SESSION SPONSOR:
• Beijing Acctrue Technology